Evaluation of the Efficacy and Safety of the Conversion From a Calcineurin Inhibitor to an Everolimus-Based Therapy in Maintenance Renal Transplant Patients

Sirolimus for Kaposi's Sarcoma in Renal-Transplant Recipients

Giovanni Stallone, Antonio Schena, Barbara Infante et al. · New England Journal of Medicine · 2005 · 976 citations · Full text

Sirolimus Therapy after Early Cyclosporine Withdrawal Reduces the Risk for Cancer in Adult Renal Transplantation

Josep M. Campistol, Josette Eris, Rainer Oberbauer et al. · Journal of the American Society of Nephrology · 2006 · 472 citations

Transplantation Medicine, Dermatology, Srl Therapy +18

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

Rainer Oberbauer, Giuseppe Segoloni, Josep M. Campistol et al. · Transplant International · 2004 · 224 citations

Sirolimus-Based Therapy Following Early Cyclosporine Withdrawal Provides Significantly Improved Renal Histology and Function at 3 Years

Alfredo Mota, Manuel Arias, E Taskinen et al. · American Journal of Transplantation · 2004 · 218 citations · Full text

Rapamycin-Induced Endothelial Cell Death and Tumor Vessel Thrombosis Potentiate Cytotoxic Therapy against Pancreatic Cancer

Christiane J. Bruns, Gudrun E. Koehl, Markus Guba et al. · Clinical Cancer Research · 2004 · 113 citations